PTX Key Stats
|Revenue (Quarterly YoY Growth)||0.89%|
|EPS Diluted (TTM)||-0.5978|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-21.46M|
|Gross Profit Margin (Quarterly)||47.68%|
|Profit Margin (Quarterly)||-33.06%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- Narrow-than-Expected Loss at Pernix - Analyst Blog Zacks Nov 14
- Cantor Raises Pernix Therapeutics (PTX) to Hold, Co May Explore Strategic Alternatives Street Insider Nov 13
- Pernix Therapeutics (PTX) PT Lowered at Needham & Company; 'Buy' Maintained Street Insider Nov 13
- Guggenheim Downgrades Pernix Therapeutics (PTX) to Neutral Street Insider Nov 13
- Stifel Nicolaus Downgrades Pernix Therapeutics (PTX) to Hold (Earlier) Street Insider Nov 12
- Unusual 11 Mid-Day Movers 11/12: (VNDA) (IOC) (HTLD) Higher; (SRPT) (DM) (HNR) Lower Street Insider Nov 12
- Pernix Therapeutics Holdings (PTX) Posts Q3 Loss of 16c/Share Street Insider Nov 12
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Other Events Oct 31
- Pernix Co-Promotes with Cumberland - Analyst Blog Zacks Oct 29
- Pernix Co-Promotes with Cumberland Oct 29
PTX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pernix Therapeutics is down 68.22% over the last year vs S&P 500 Total Return up 30.24%, Mylan up 56.91%, and Actavis up 82.39%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for PTX
Pro Strategies Featuring PTX
Did Pernix Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a variety of therapeutic areas.